TP53 and cancer: In a previous study, we showed that TP53 variants resulting from dinucleotide (DNS) or trinucleotide substitutions (TNS) at hotspot codons 175, 248 and 273 could be highly deleterious for TP53 activity but were never observed in human cancer due to the very low probability of such events8.